Amylyx Pharmaceuticals, Inc.

AMLX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091436
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Sell

Net shares

-6,844

% of shares

-4.84%

Amount (USD)

$99,378

Insider confidence score

42.5 out of 100

Positive

  • Tax withholding obligation

Negative

  • Large tax withholding sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-6,844.0

Price per Share

$14.52

Amount (USD)

$99,378.30

Acquired/Disposed

Disposed

Shares Owned Before

141,274.0

Shares Owned After

134,430.0

Filing's footnotes

1. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.400 to $15.070. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.